BIODESIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 USD | +2.31% |
|
-6.99% | -27.72% |
| 05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
| 05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIODESIX, INC. | Medical & Diagnostic Laboratories | +2.31% | -6.99% | -27.72% | -8.90% | - | 193M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BDSX Stock
- Charts Biodesix, Inc.
- Comparison Chart